Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,002.70, with a market capitalization of 951.29B. The stock trades at a price-to-earnings (P/E) ratio of 43.15 and offers a dividend yield of 62.9%.
As of 2026-03-09, Eli Lilly(LLY) stock has fluctuated between $977.00 and $1,008.86. The current price stands at $1,002.70, placing the stock +2.6% above today's low and -0.6% off the high.
Eli Lilly(LLY) shares are trading with a volume of 2.8M, against a daily average of 2.94M.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
LLY News
In the latest close session, Eli Lilly (LLY) was up +1.82% at $1,008.39. This move outpaced the S&P 500's daily gain of 0.83%. Elsewhere, the Dow gained 0.5%, w...
Key Points Eli Lilly stock is down 13% from its 52-week high. Analysts still see some decent upside for the stock, with its average price target being north o...
Eli Lilly and Co. (LLY) is turning to South Korea for its next big investment. The U.S. pharmaceutical giant has agreed to invest $500 million in South Korea o...
Analyst ratings
80%
of 35 ratingsMore LLY News
How Roche Hopes To Go Toe-To-Toe With Eli Lilly, Novo Nordisk In Obesity 1/29/2026 Roche hopes to rival Eli Lilly and Novo Nordisk in the red-hot weight-loss s...
Amazon Pharmacy (AMZN) announced expanded access to the new Zepbound KwikPen through Amazon Pharmacy. Eli Lilly’s (LLY) multi-dose injectable treatment for weig...
Eli Lilly (LLY) is in focus after launching its Employer Connect platform for Zepbound, giving U.S. employers new ways to structure obesity drug coverage and wo...
Eli Lilly (LLY +0.70%) wasn't the first to market with a GLP-1 drug. However, its Mounjaro (for diabetes) and Zepbound (for weight loss) drugs have proven more...
Is Novo Nordisk (NVO 1.27%) a bargain or a value trap as it battles Eli Lilly (LLY +0.70%) for GLP‑1 leadership, execution credibility, and premium growth? Watc...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The Phase 1b study “A Phase 1b Study of Abemaciclib Plus Darolutamide in Men W...
U.S. pharmaceutical giant Eli Lilly (LLY) has launched a new program designed to help more employers cover the cost of weight-loss medications. Currently, a la...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.